NCT07572175 clinical trial report covering Sotagliflozin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07574684 clinical trial report covering Lipoic acid, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07576608 clinical trial report covering 9MW3811, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07575932 clinical trial report covering Berobenatide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07574528 clinical trial report covering Sintilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07575412 clinical trial report covering Zeprumetostat, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07575308 clinical trial report covering ALN-6400, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07574541 clinical trial report covering Nogapendekin alfa inbakicept-pmln, Phase 2, endpoints, sponsor, geography, readout timing and development white spa

NCT07576725 clinical trial report covering Nivolumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600124258 clinical trial report covering Octreotide Acetate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261815 clinical trial report covering KAL-002, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600124305 clinical trial report covering Artenimol, Phase 2, endpoints, sponsor, geography, readout timing and development white space.